Table of Contents
Applying Evidence in Interventional Oncology
Practical discussions on the growing literature base.
In This Issue
Guest Chief Medical Editors' Page
Tumor Boards in Interventional Oncology
A multidisciplinary discussion of the approach to treatment for four patients with cancers of varying origins and severities.
With Ghassan K. Abou-Alfa, MD; Justin D. Blasberg, MD; Frank C. Detterbeck, MD, FACS, FCCP; Dimitris Filippiadis, MD, PhD, EBIR; Ryan Hickey, MD; Howard S. Hochster, MD; Zeljka Jutric, MD; Alexis Kelekis, MD, PhD, EBIR, FSIR; Maureen P. Kohi, MD, FSIR; Alexander Lam, MD; Robert J. Lewandowski, MD, FSIR; Areo Saffarzadeh, MD, MS; Mansi R. Shah, MD; Ronald F. Wolf, MD; Emi J. Yoshida, MD; and Etay Ziv, MD, PhD
Metastatic Osseous Disease: Current Interventional Oncology Treatment Options
Minimally invasive therapies such as embolization, thermal ablation, and consolidative therapy can be used for locoregional control and pain palliation or can be combined for a synergistic effect.
By Steven Yevich, MD, MPH
Perspectives: Pancreatic Cancer Interventions: The End of the Beginning?
Experts weigh in on the current roles of various therapeutic options for pancreatic cancer.
With Govindarajan Narayanan, MD; Thomas Scagnelli, MD; Mehul Doshi, MD; Shalini Moningi, MD; Maureen Aliru, BS; Joseph M. Herman, MD, MSc, MSHCH, FACR; Jordan M. Cloyd, MD; Timothy M. Pawlik, MD, MPH, PhD; Mohammad Alasker, MD; and David K. Imagawa, MD, PhD, FACS
Medical Affairs Corner
Sponsored by MEDTRONIC